Gene therapy gives Manchester boy his life back
A 13-year-old from Oldham received Casgevy (exa-cel), a one-time CRISPR-based gene-editing treatment for beta-thalassaemia in November 2024 and has returned to Royal Manchester Children's Hospital to thank the staff who cared for him.
